Mediorals Laboratories Private Limited
About Mediorals Laboratories Private Limited
Data last updated:
Mediorals Laboratories Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 October 1985.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH1985PTC037675.
The company had an authorised share capital of ₹2.54 Cr and a paid-up capital of ₹2.54 Cr.
Its last annual general meeting (AGM) was held on 30 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office was at 12 Gunbow Streetfort, Mumbai, Maharashtra, India – 400001.
As per the financials filed for FY 2016, the company reported a revenue of ₹17.53 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.39 Cr and EBITDA of ₹1.43 Cr.
Its group structure includes 2 subsidiaries.
As per MCA filings, the company has satisfied charges of ₹5.43 Cr on record.
Company details
Contact details
Mediorals Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address12 Gunbow Streetfort, Mumbai, Maharashtra, India – 400001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mediorals Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Mediorals Laboratories Private Limited
FY 2016 filings availableMediorals Laboratories Private Limited reported revenue of ₹17.53 Lakh (up 1476% YoY) for FY 2016.
Financial Statement Summary
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ₹17.53 Lakh | |
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹1.43 Cr | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹1.39 Cr | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Mediorals Laboratories Private Limited, buy the company report.
Board of directors of Mediorals Laboratories Private Limited
Mediorals Laboratories has 5 former directors on record and no current directors listed.
Peer comparison
Mediorals Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Curapro Formulations and Hygienic Private Limited | ₹17.68 Lakh (FY 2021) | 164.0% | Chinchwad, Maharashtra, India | |||
| Makjai Laboratories Pvt Ltd | ₹17.68 Lakh (FY 2022) | -83.0% | Kolhapur, Maharashtra, India | |||
| Ba Alavi Sadath Ayurvedic Research (India) Private Limited | ₹17.67 Lakh (FY 2025) | 46.0% | Malappuram, Kerala, India | |||
| Dext Parental Private Limited | ₹17.63 Lakh (FY 2024) | 61.0% | New Delhi, Delhi, India | |||
| Tenshi KSM Private Limited | ₹17.6 Lakh (FY 2021) | -82.0% | Bangalore, Karnataka, India | |||
| Mediorals Laboratories Private Limitedthis company | ₹17.53 Lakh (FY 2016) | ₹1.39 Cr | 1476.0% | Mumbai, Maharashtra, India | ||
| Eagle Laboratories Pvt Ltd | ₹17.51 Lakh (FY 2024) | 19.0% | Kolkata, West Bengal, India | |||
| Zyllexa Formulations Private Limited | ₹17.48 Lakh (FY 2023) | -34.0% | Bilathikulam, Kerala, India | |||
| Reagene Biosciences Private Limited | ₹17.47 Lakh (FY 2023) | -1.0% | Bengaluru, Karnataka, India | |||
| Satiate Agri Limited | ₹17.39 Lakh (FY 2025) | -15.0% | Indore, Madhya Pradesh, India | |||
| SRS Therapeutics Private Limited | ₹17.38 Lakh (FY 2021) | 234.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Mediorals Laboratories Private Limited, buy the company report.
Auditor
Mediorals Laboratories Private Limited is audited by ABHAY KALE & CO for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ABHAY KALE & CO | FY 2016 | 128773W |
Shareholding
The shareholding of Mediorals Laboratories Private Limited is on record for 2 financial years, the latest being FY 2016, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2016 | FY 2015 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Mediorals Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 May 2001 | 90166714 | Bnp Paribas | ₹1 Cr | Satisfied | |
| 17 Apr 2000 | 90166860 | Banque National De Paris | ₹1 Cr | Satisfied | |
| 29 Aug 1998 | 90163759 | The Hongkong and Shanghai Banking Corporation Limited | ₹3.43 Cr | Satisfied |
To see the full charge records of Mediorals Laboratories Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Mediorals Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mediorals Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Mediorals Laboratories has 2 subsidiary companies. This group structure data is as of FY 2016. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Exind Trading Private Limited | U51909MH2004PTC149452 | |
| Exind Trading Private Limited | U51909MH2004PTC149452 |
To see the full group structure of Mediorals Laboratories Private Limited, buy the company report.
GST
No GST registration is on our record for Mediorals Laboratories Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mediorals Laboratories Private Limited has 6 board changes on record since 2009: 0 appointments and 6 cessations. The latest: Chandrakant Nanasaheb Bhosekar ceased to be Director on 11 Feb 2017.
4 earlier events are in the company report.
Frequently asked questions
Mediorals Laboratories has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Mediorals Laboratories was a private limited company based in Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 08 October 1985 and is registered under CIN U24110MH1985PTC037675. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Mediorals Laboratories is U24110MH1985PTC037675. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mediorals Laboratories was incorporated on 08 October 1985. It is registered with the Registrar of Companies, Mumbai.
The registered office of Mediorals Laboratories is at 12 Gunbow Streetfort, Mumbai, Maharashtra, India – 400001.
The latest financial statements of Mediorals Laboratories on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 30 September 2016. Year-wise statements from 2015 are in the company report.
Mediorals Laboratories operated in the pharma industry, in the drug formulation and development segment.
The peers of Mediorals Laboratories by revenue are Curapro Formulations and Hygienic Private Limited, Makjai Laboratories Pvt Ltd, Ba Alavi Sadath Ayurvedic Research (India) Private Limited, Dext Parental Private Limited, Tenshi KSM Private Limited and 5 more, all in the Pharma industry (Formulations).
Chandrakant Nanasaheb Bhosekar ceased to be Director on 11 Feb 2017. Hemant Satwikrao Lokhande ceased to be Director on 11 Feb 2017. Hemant Satwikrao Lokhande ceased to be Director on 11 Feb 2017. Mediorals Laboratories has 6 board changes on record in total.
Mediorals Laboratories has no open charges and satisfied charges of ₹5.43 Cr as per latest MCA filings.
Mediorals Laboratories has 2 subsidiary companies including Exind Trading Private Limited, Exind Trading Private Limited.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
